Cohance Lifesciences Ltd

Cohance Lifesciences is a technology-led, integrated CDMO and API+ platform formed by combining RA Chem, Avra, ZCL, Suven Pharma, Sapala, and NJ Bio. It brings together deep expertise in R&D, manufacturing, and customer partnerships to create end-to-end solutions across the life sciences value chain. Operating across Pharma CDMO, Agrochemical CDMO, API, and Formulations, Cohance specializes in cutting-edge technologies like Antibody Drug Conjugates (ADCs) and Oligonucleotides. With a strong global presence, Cohance serves leading innovators in the US, Europe, Japan, and beyond, supporting them from early development to commercial manufacturing across both pharmaceutical and agrochemical domains.